Promising imaging developments may soon improve clinicians' ability to diagnose and monitor the progression of multiple sclerosis (MS). Dr Patricia Coyle, director of the Multiple Sclerosis Comprehensive Care Center at Stony Brook University Medical Center, reports on findings presented at the 8th Joint ACTRIMS-ECTRIMS Conference, this year known as MSVirtual 2020.
Dr Coyle emphasizes the importance of appropriate diagnosis as well as the need to improve the misdiagnosis rate. Advanced monitoring techniques that can detect MS with more accuracy are key.
She highlights exciting research in novel MRI markers, including central vein sign and paramagnetic rim sign (PRS). One study shows reliable methods for quantification of PRS, which is especially critical if this prognostic marker is to be adopted for clinical practice.
INFORMATION FROM INDUSTRY
Resources
Have You Seen the Head-to-Head Efficacy Data for ZEPOSIA® (ozanimod)?
Clinical Trial Safety Findings for an S1P Therapy
Discover How to Start Appropriate Patients on an S1P
US-ZEP-20-0997 10/20
Dr Coyle highlights other studies focused on techniques that help monitor the damage from progressing MS, including further analysis of optical coherence tomography.
Patricia K. Coyle, MD, Professor, Interim Chair, Director, Multiple Sclerosis Comprehensive Care Center, Department of Neurology, Stony Brook University Medical Center, Stony Brook, New York